Cassava Sciences | PTIE - Nettoeinkommen





Nettoeinkommen Veränderung Datum
Abbott USD 928M 149M 2026-06
Amgen USD 2.38B 556M 2026-06
Biogen USD 97.5M 222M 2026-06
Cara Therapeutics USD -6.8M 1.28M 2026-03
Cassava Sciences USD -10.33M 2.21M 2026-03
Eisai JPY 18.24B 21.49B 2026-06
Eli Lilly USD 7.1B 301M 2026-06
Geron USD -3.64M 27.5M 2026-03
J&J USD 5.53B 299M 2026-06
Merck USD -1.34B 2.9B 2026-06
Novartis USD 3.26B 108M 2026-06
Novavax USD 17.53M 219.91M 2025-12
Pfizer USD -248M 2.94B 2026-06
Roche Holding CHF 6.87B 1.4B 2026-06